 Home > Active Ingredient News > Antitumor Therapy > NICE recommends Bavncio (avelumab) for locally advanced metastatic urothelial carcinoma (UC)

NICE recommends Bavncio (avelumab) for locally advanced metastatic urothelial carcinoma (UC)

 Last Update: 2022-05-21
 Source: Internet
 Author: User

Tags

group science

humidity control device

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The UK's National Institute for Health and Care Excellence (NICE) recommends immunotherapy Bavncio (avelumab) as a maintenance treatment option for eligible adult patients with locally advanced metastatic urothelial carcinoma (UC)

immunity

Bladder cancer generally refers to various malignant tumors arising from the bladder

diagnosis

NICE's decision marks avelumab as the first and only monotherapy for first-line maintenance therapy in adult patients with locally advanced or metastatic UC who have not progressed after platinum-based chemotherapy

A phase III trial enrolled patients with unresectable locally advanced or metastatic urothelial carcinoma

The 1-year overall survival rate was 71.

Figure 1.

OS in the avelumab group vs.

Original source:

https:// href="https://" target="_blank" rel="noopener">https:// https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Top Product

$100/KG EXW

Dacarbazine 99% Factory price White Powder cas4342-03-4 Dacarbazine

CAS No.: 4342-03-4

Pharmacy Grade

$158-168/KG FOB

Anti-Cancer Pirespa Powder CAS 53179-13-8 Pirfenidone 5-methyl-1-phenylpyridin-2-one

CAS No.: 53179-13-8

Pharmacy Grade

$4/G FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.